Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis (Cancer-DACUS)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2009 by Azienda Ospedaliera Universitaria Policlinico.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Azienda Ospedaliera Universitaria Policlinico
Information provided by:
Azienda Ospedaliera Universitaria Policlinico
ClinicalTrials.gov Identifier:
NCT00450645
First received: March 20, 2007
Last updated: March 3, 2009
Last verified: March 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2011 |
| Estimated Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |